查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1262057

替代癌症治療市場-全球行業規模、份額、趨勢、機會、預測，2018-2028 年，按治療類型、按疾病類型、按最終用戶、按地區、競爭

Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Therapy Type, By Disease Type, By End Users, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球癌症替代療法市場有望在預測期內實現顯著增長。

其背景是老齡化社會的到來，更容易患上各種類型的癌症。 此外，老齡化社會對新療法的認識不斷提高，以及市場進入者數量的增加，也是預測期內進一步推動市場增長的主要因素。 此外，用於疼痛管理的針灸、芳香療法和瑜伽等替代療法的迅速普及將進一步推動預測期內的市場增長。 此外，增加替代癌症治療的保險範圍以及政府組織增加對人們進行新療法教育的舉措預計將推動多年來的市場增長。

癌症患病率增加

世界上大多數人對酒精、煙草和不健康食品的消費增加了腺癌、淋巴瘤、胃腸道間質瘤、肺癌和乳腺癌的發病率。它推動了預測期內的市場增長。 同樣，易患胃癌等慢性病的老年人口不斷增加，胃癌是全球老年男性中最常見的癌症殺手之一，將在預測期內推動市場增長。我猜。 2022 年，美國國家癌症研究所估計，美國將有大約 26,380 例胃癌新病例和 11,090 例胃癌死亡病例。 在發展中國家，男性比女性更容易患胃癌。 不僅在北美地區，而且在世界各個地區，胃癌患病率的上升增加了對治療患者的有效療法的需求，這推動了預測期內的市場增長。預計將鼓勵增長。 例如，根據加拿大癌症協會公佈的2021年統計數據，預計2021年將有4000名加拿大人患上胃癌。 同樣，多年來政府為促進採用替代癌症治療而採取的更多舉措也促進了市場增長。 此外，印度阿尤什部由印度政府設立，負責調查與自然療法、阿育吠陀和順勢療法藥物的教育、產品和研究相關的事宜。 因此，政府對替代療法增長的投資不斷增加，推動了對各種補充和替代癌症療法的需求。

醫療支出增加

由於醫療保健行業研發部門的技術不斷發展以及癌症診斷中替代療法的利用，預計在預測期內對替代癌症療法的需求將產生可觀的增長。 同樣，私人和政府機構在製藥和生物技術公司的支持下支持研發部門，這進一步推動了預測期內的市場增長。 癌症研究的資金正在迅速增加，其中大部分政府資金用於乳腺癌和兒童癌症。 2019 年，美國國立衛生研究院 (NIH) 在乳腺癌方面的投資為 4.6 億美元，到 2022 年將增加到 35 億美元。

近期發展

  • 2018 年 2 月，加拿大衛生部宣布，Janssens Zytiga 與潑尼松聯合使用已接受長達 3 個月的雄激素剝奪治療的新診斷高危轉移性激素敏感性前列腺癌患者獲得批准和雄激素剝奪療法治療
  • 2020 年 4 月，美國 FDA 批准 Trodelvy (sacituzumab govitecan-hziy) 用於治療成年三陰性乳腺癌患者。 Trodelvy 是一種 Trop-2 共免疫和拓撲異構□抑製劑製劑，專注於 Trop-2 受體，有助於癌症的發生、分離和擴散。

可用的自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第五章全球抗癌替代藥物市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按地區
    • 按公司分類（2022 年）
  • 產品地圖
    • 按治療類型
    • 按疾病類型
    • 最終用戶
    • 按地區

第六章北美抗癌替代藥物市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第七章：歐洲抗癌替代藥物市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太替代抗癌藥物市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9章南美抗癌替代藥物市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲的替代抗癌藥物市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按療法類型（激素療法、針灸、營養補充劑等）
    • 按疾病分類（胃腸癌、肺癌、乳腺癌、結直腸癌、白血病、淋巴瘤、黑色素瘤、前列腺癌等）
    • 按最終用戶（醫院/診所、癌症/放射治療中心、家庭護理等）
    • 按國家
  • MEA：國家分析
    • 南非替代抗癌藥
    • 沙特阿拉伯癌症替代療法
    • 阿聯酋替代抗癌藥

第 11 章市場動態

  • 司機
    • 癌症患者增加
    • 不斷增長的醫療支出
  • 做
    • 缺乏對新療法的認識
    • 昂貴的醫療費用

第12章市場趨勢與發展

  • 近期發展狀況
  • 併購
  • 產品發布

第 13 章全球抗癌替代藥物市場：SWOT 分析

第 14 章波特的五力分析

  • 行業競爭
  • 新進入的可能性
  • 供應商的力量
  • 客戶力量
  • 替代品的威脅

第15章競爭格局

  • 業務概覽
  • 提供的產品
  • 近期發展狀況
  • 財務（據報導）
  • 主要人物
  • SWOT 分析
    • Innovative Medicine, LLC
    • Northwest Natural Health Clinic
    • Immunotherapy Institute
    • Georgia Cancer Specialists
    • Holistic Bio Spa
    • Johnson & Johnson
    • Celgene Corporation
    • Astellas Pharma, Inc.
    • Novartis AG
    • Merck KGaA

第16章 策略建議

簡介目錄
Product Code: 14702

Global Alternative Cancer Therapeutics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising aging population, which is susceptible to different types of cancers. Additionally, the growing number of market players, along with growing awareness of new therapies among the aging population, is a major factor that will further drive the growth of the market during the forecast period. Also, the rapidly growing adoption of new therapies such as acupuncture, aromatherapy, yoga, and other alternative therapies for pain management will further drive the growth of the market in the forecast period. Also, growing insurance coverage for alternative cancer treatment, along with growing initiatives by government organizations to educate people about new therapy, will drive the growth of the market over the years.

Growing Prevalence of Cancer

The increasing incidence of adenocarcinoma, lymphoma, and gastrointestinal stromal tumors, lung cancer, breast cancer due to the consumption of alcohol, tobacco, and unhealthy food by the majority of the population across the world is driving the market growth during the forecast period. Similarly, the rising aging population, which is susceptible to chronic diseases like stomach cancer, one of the most common deadly cancers worldwide among older males, will boost the market growth in the forecast period. In 2022 the National Cancer Institute estimated around 26,380 new stomach cancer cases and 11,090 deaths in the United States. In developing countries, stomach cancer is diagnosed more in males than females. The increasing prevalence of gastric cancer across the North American region and also across different parts of the globe has increased the demand for effective therapies for treating patients, which in turn is expected to propel the market growth during the forecast period. For instance, according to the 2021 statistics published by the Canadian Cancer Society, 4,000 Canadians were estimated to develop gastric cancer in 2021. Similarly, growing initiatives by the government to promote the adoption of alternative cancer therapeutics are also boosting the growth of the market over the years. Also, the Ministry of Ayush in India was set up by the government of India to look into matters related to the education, product, and research of naturopathy, Ayurveda, and homeopathy medicines. Therefore, the rising government investments in the growth of alternative therapies is fuelling the demand for various complementary and alternative cancer treatment.

Rising Healthcare Expenditure

Due to the increasing technological developments in the research and development sector in the healthcare industry and the use of alternative therapies in cancer diagnosis, the demand for alternative cancer therapy is expected to create a lucrative growth in the forecast period. Similarly, private and government organizations are supporting the research and development sector with the help of pharmaceutical and biotechnology firms which is further boosting the market growth in the forecast period. The funding for cancer research is rapidly increasing, and most of the government funding is for breast cancer and childhood cancer. In 2019 the National Institutes of Health (NIH) invested USD460 million in breast cancer, which increased to USD3.5 billion in the year 2022.

Market Segmentation

Global alternative cancer therapeutics market can be segmented on therapy type, disease type, end users, region, and competitive landscape. Based on the therapy type, the market can be segmented into Hormone Therapies, Acupuncture, and Dietary Supplements, among Others. Based on Diseases Type, the market can be segmented into Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, and Others. Based on the End Users, the market can be differentiated into Hospitals and Clinics, cancer and Radiation Therapy Centers, Home Care, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global alternative cancer therapeutics market on account of the increasing incidence of different types of cancer in the country.

Recent Developments

  • In February 2018, Health Canada approved Janssens Zytiga in combination with prednisone and androgen deprivation therapy for the treatment of patients with newly diagnosed, high-risk metastatic hormone-sensitive prostate cancer who have received up to three months of prior androgen deprivation therapy.
  • In April 2020, the US FDA supported Trodelvy (sacituzumab govitecan-hziy) for the therapy of adult patients with triple-negative breast cancer. Trodelvy is a Trop-2-coordinated immunizer and topoisomerase inhibitor drug form which focuses on the Trop-2 receptor that helps cancer develop, separate, and spread.

Market Players

Innovative Medicine, LLC. , Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Novartis AG, and Merck KGaA are some of the leading players operating in the Global Alternative Cancer Therapeutics Market.

Report Scope

In this report, global alternative cancer therapeutics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Alternative Cancer Therapeutics Market, By Therapy Type:

  • Hormone Therapies
  • Acupuncture and Dietary Supplements
  • Others

Alternative Cancer Therapeutics Market, By Disease Type:

  • Gastrointestinal
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia,
  • Lymphoma
  • Melanoma
  • Prostate Cancer
  • Others

Alternative Cancer Therapeutics Market, By End Users:

  • Hospitals and Clinics
  • Cancer and Radiation Therapy Center
  • Home Care
  • Others

Alternative Cancer Therapeutics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Alternative Cancer Therapeutics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Therapy Type
    • 5.3.2. By Disease Type
    • 5.3.3. By End Users
    • 5.3.4. By Region

6. North America Alternative Cancer Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Alternative Cancer Therapeutics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Therapy Type
        • 6.3.1.2.2. By Disease Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Therapy Type
        • 6.3.2.2.2. By Disease Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Therapy Type
        • 6.3.3.2.2. By Disease Type
        • 6.3.3.2.3. By End User

7. Europe Alternative Cancer Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Alternative Cancer Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy Type
        • 7.3.1.2.2. By Disease Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy Type
        • 7.3.2.2.2. By Disease Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy Type
        • 7.3.3.2.2. By Disease Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Therapy Type
        • 7.3.4.2.2. By Disease Type
        • 7.3.4.2.3.
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Therapy Type
        • 7.3.5.2.2. By Disease Type
        • 7.3.5.2.3. By End User

8. Asia-Pacific Alternative Cancer Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Alternative Cancer Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy Type
        • 8.3.1.2.2. By Disease Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Alternative Cancer Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy Type
        • 8.3.2.2.2. By Disease Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy Type
        • 8.3.3.2.2. By Disease Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy Type
        • 8.3.4.2.2. By Disease Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy Type
        • 8.3.5.2.2. By Disease Type
        • 8.3.5.2.3. By End User

9. South America Alternative Cancer Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy Type
        • 9.3.1.2.2. By Disease Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy Type
        • 9.3.2.2.2. By Disease Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy Type
        • 9.3.3.2.2. By Disease Type
        • 9.3.3.2.3. By End User

10. Middle East and Africa Alternative Cancer Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
    • 10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
    • 10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy Type
        • 10.3.1.2.2. By Disease Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy Type
        • 10.3.2.2.2. By Disease Type
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy Type
        • 10.3.3.2.2. By Disease Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing Prevalence of Cancer
    • 11.1.2 Growing Healthcare Expenditure
  • 11.2. Challenges
    • 11.2.1 Lack of Awareness about New Therapies
    • 11.2.2 High Cost of Treatment

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Alternative Cancer Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Innovative Medicine, LLC
    • 15.6.2. Northwest Natural Health Clinic
    • 15.6.3. Immunotherapy Institute
    • 15.6.4. Georgia Cancer Specialists
    • 15.6.5. Holistic Bio Spa
    • 15.6.6. Johnson & Johnson
    • 15.6.7. Celgene Corporation
    • 15.6.8. Astellas Pharma, Inc.
    • 15.6.9. Novartis AG
    • 15.6.10. Merck KGaA

16. Strategic Recommendations